These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 9627221)

  • 21. Reversing drug resistance in the ovarian carcinoma cell line SKOV3/mdr1 in vitro by antisense oligodeoxynucleotides.
    Pan L; Tong Y; Jin Y; Zhou S; Zhang Y; Yang X; Mao N
    Chin Med J (Engl); 2001 Sep; 114(9):929-32. PubMed ID: 11780384
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Recent advances in P-glycoprotein-mediated multidrug resistance reversal mechanisms.
    Li X; Li JP; Yuan HY; Gao X; Qu XJ; Xu WF; Tang W
    Methods Find Exp Clin Pharmacol; 2007 Nov; 29(9):607-17. PubMed ID: 18193112
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Induction of MDR1 gene expression by anthracycline analogues in a human drug resistant leukaemia cell line.
    Hu XF; Slater A; Rischin D; Kantharidis P; Parkin JD; Zalcberg J
    Br J Cancer; 1999 Feb; 79(5-6):831-7. PubMed ID: 10070877
    [TBL] [Abstract][Full Text] [Related]  

  • 24. MDR1/P-gp and VEGF synergistically enhance the invasion of Hep-2 cells with multidrug resistance induced by taxol.
    Li L; Jiang AC; Dong P; Wang H; Xu W; Xu C
    Ann Surg Oncol; 2009 May; 16(5):1421-8. PubMed ID: 19247716
    [TBL] [Abstract][Full Text] [Related]  

  • 25. P-glycoprotein expression does not change the apoptotic pathway induced by curcumin in HL-60 cells.
    Bielak-Mijewska A; Piwocka K; Magalska A; Sikora E
    Cancer Chemother Pharmacol; 2004 Feb; 53(2):179-85. PubMed ID: 14530869
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evaluation of MDR1, LRP, MRP, and topoisomerase IIalpha gene mRNA transcripts before and after interferon-alpha, and correlation with the mRNA expression level of the telomerase subunits hTERT and TEP1 in five unselected human melanoma cell lines.
    Miracco C; Maellaro E; Pacenti L; Del Bello B; Valentini MA; Rubegni P; Pirtoli L; Volpi C; Santopietro R; Tosi P
    Int J Oncol; 2003 Jul; 23(1):213-20. PubMed ID: 12792796
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Establishment of hepatocellular carcinoma multidrug resistant monoclone cell line HepG2/mdr1.
    Chen YB; Yan ML; Gong JP; Xia RP; Liu LX; Li N; Lu SC; Zhang JG; Zeng DB; Xie JG; Yang JY; Yan LN
    Chin Med J (Engl); 2007 Apr; 120(8):703-7. PubMed ID: 17517188
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Persistent reversal of P-glycoprotein-mediated daunorubicin resistance by tetrandrine in multidrug-resistant human T lymphoblastoid leukemia MOLT-4 cells.
    Liu ZL; Hirano T; Tanaka S; Onda K; Oka K
    J Pharm Pharmacol; 2003 Nov; 55(11):1531-7. PubMed ID: 14713364
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Inhibition of expression of the multidrug resistance-associated P-glycoprotein of by phosphorothioate and 5' cholesterol-conjugated phosphorothioate antisense oligonucleotides.
    Alahari SK; Dean NM; Fisher MH; Delong R; Manoharan M; Tivel KL; Juliano RL
    Mol Pharmacol; 1996 Oct; 50(4):808-19. PubMed ID: 8863825
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Multidrug-resistant phenotype influences the differentiation of a human colon carcinoma cell line.
    Rimet O; Mirrione A; Barra Y
    Biochem Biophys Res Commun; 1999 May; 259(1):43-9. PubMed ID: 10334913
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Imatinib resistance in multidrug-resistant K562 human leukemic cells.
    Assef Y; Rubio F; Coló G; del Mónaco S; Costas MA; Kotsias BA
    Leuk Res; 2009 May; 33(5):710-6. PubMed ID: 18977528
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Direct current decreases cell viability but not P-glycoprotein expression and function in human multidrug resistant leukemic cells.
    Holandino C; Veiga VF; Rodrigues ML; Morales MM; Capella MA; Alviano CS
    Bioelectromagnetics; 2001 Oct; 22(7):470-8. PubMed ID: 11568932
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Lentivirus-mediated RNA interference reversing the drug-resistance in MDR1 single-factor resistant cell line K562/MDR1.
    Ye X; Liu T; Gong Y; Zheng B; Meng W; Leng Y
    Leuk Res; 2009 Aug; 33(8):1114-9. PubMed ID: 19036441
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Modulating multidrug resistance gene in leukaemia cells by short interfering RNA.
    Lim MN; Lau NS; Chang KM; Leong CF; Zakaria Z
    Singapore Med J; 2007 Oct; 48(10):932-8. PubMed ID: 17909680
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Flow cytometric evaluation of fas expression in relation to response and resistance to anthracyclines in leukemic cells.
    Labroille G; Dumain P; Lacombe F; Belloc F
    Cytometry; 2000 Mar; 39(3):195-202. PubMed ID: 10685076
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Suppression of P-glycoprotein gene expression in Hs578T/Dox by the overexpression of caveolin-1.
    Zhu H; Cai C; Chen J
    FEBS Lett; 2004 Oct; 576(3):369-74. PubMed ID: 15498565
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Reversal effect of isotetrandrine, an isoquinoline alkaloid extracted from Caulis Mahoniae, on P-glycoprotein-mediated doxorubicin-resistance in human breast cancer (MCF-7/DOX) cells.
    Wang TX; Yang XH
    Yao Xue Xue Bao; 2008 May; 43(5):461-6. PubMed ID: 18717331
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of MDR1 phosphorothioate antisense oligodeoxynucleotides in multidrug-resistant human tumor cell lines and xenografts.
    Ramachandran C; Wellham LL
    Anticancer Res; 2003; 23(3B):2681-90. PubMed ID: 12894558
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Selection of antisense oligonucleotides for reversal of multidrug resistance in breast carcinoma cells.
    Gao P; Zhou GY; Lei DP; Zhang XF; Li L; Xu JW; Lin XY
    Cytotherapy; 2007; 9(8):795-801. PubMed ID: 17917879
    [TBL] [Abstract][Full Text] [Related]  

  • 40. COX-2 contributes to P-glycoprotein-mediated multidrug resistance via phosphorylation of c-Jun at Ser63/73 in colorectal cancer.
    Sui H; Zhou S; Wang Y; Liu X; Zhou L; Yin P; Fan Z; Li Q
    Carcinogenesis; 2011 May; 32(5):667-75. PubMed ID: 21296766
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.